Compounders Research Compare

Outset Medical, Inc.(OM)

Medical - Devices · San Jose, CA

$4.14+0.04 (+0.98%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Outset Medical, Inc.

Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.

San Jose, CA

310 employees

www.outsetmedical.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Leslie L. Trigg

View full financials

Price/FCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T21:33:21.784Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:33:21.784Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 76,744,174
TTM free cash flow · period ending 2026-06-30: -38,879,000

FMP input reference: e005637c0728ee7719d987fd9d1ed1bb4b4a72c9577e4c0c1fad472fb0ddb1d0

P/E Ratio|FCF Growth|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

OM Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

OM Competitors' Price/FCF Ratio

Outset Medical, Inc.

Current

Market Cap

$76.74M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Neonc Technologies Holdings, Inc.

Market Cap

$77.54M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SkinHealth Systems Inc.

Market Cap

$75.95M

Price/FCF Ratio

4.56

TTM Avg

5.17

3Y Avg

25.10

5Y Avg

25.10

Inovio Pharmaceuticals, Inc.

Market Cap

$78.07M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Sera Prognostics, Inc.

Market Cap

$78.29M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Pulmonx Corporation

Market Cap

$75.18M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

vTv Therapeutics Inc.

Market Cap

$78.59M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Citius Oncology, Inc.

Market Cap

$79.03M

Price/FCF Ratio

N/A

TTM Avg

786.60

3Y Avg

786.60

5Y Avg

786.60

Acrivon Therapeutics, Inc. Common Stock

Market Cap

$79.61M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Hyperfine, Inc.

Market Cap

$73.27M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Outset Medical, Inc. (OM)	$76.74M	N/A	N/A	N/A	N/A
Neonc Technologies Holdings, Inc. (NTHI)vs ›	$77.54M	N/A	N/A	N/A	N/A
SkinHealth Systems Inc. (SKIN)vs ›	$75.95M	4.56	5.17	25.10	25.10
Inovio Pharmaceuticals, Inc. (INO)vs ›	$78.07M	N/A	N/A	N/A	N/A
Sera Prognostics, Inc. (SERA)vs ›	$78.29M	N/A	N/A	N/A	N/A
Pulmonx Corporation (LUNG)vs ›	$75.18M	N/A	N/A	N/A	N/A
vTv Therapeutics Inc. (VTVT)vs ›	$78.59M	N/A	N/A	N/A	N/A
Citius Oncology, Inc. (CTOR)vs ›	$79.03M	N/A	786.60	786.60	786.60
Acrivon Therapeutics, Inc. Common Stock (ACRV)vs ›	$79.61M	N/A	N/A	N/A	N/A
Hyperfine, Inc. (HYPR)vs ›	$73.27M	N/A	N/A	N/A	N/A

Free Cash Flow Valuation

P/FCF Ratio

N/A

FCF Yield

N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Growth Operating Margin All Metrics